Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds



Advances in Translational Research for CNS Diseases

Posted on: 28 Oct 04


Learn about new methods and innovative tools to help you with your translational research.

As you know, translational research is a crucial bridge between pre-clinical and clinical trials for CNS diseases.  Its value is determined by how well it can map a drug’s physiological effects and predict the likelihood that it will be successful in clinical trials.  Consequently, the better and more precise the translational research, the more money will be saved during drug development and the quicker a drug can successfully reach market.

            Since translational research is bi-directional in nature, working from the laboratory to the clinic, and from the clinic back to the laboratory, it is inherently collaborative.  To help foster these collaborations and provide practical tools and techniques to improve translation research Pharmaceutical Education Associates is proud to present “Advances in Translational Research for CNS Diseases.”

Jennifer McGinnis

Last updated on: 27/08/2010 11:40:18

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.